N. Nagata

Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial

Kunitoshi Iseki, H. Arima, Kentaro Kohagura et al. · Nephrology Dialysis Transplantation · 2013 · 98 citations

Medicine, Pharmacology, Pharmacotherapy +17

FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study

Shigeyoshi Iwamoto, Tsuyoshi Takahashi, Hiroshi Tamagawa et al. · Annals of Oncology · 2015 · 66 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A1*28/*6 Polymorphisms

Yusuke Okuyama, Shoichi Hazama, Hiroshi Nozawa et al. · Japanese Journal of Clinical Oncology · 2011 · 54 citations · Full text

Medicine, Genetics, Oncology +16

Specific sensitization of Lyt-1+2- T cells to spleen cells modified by the drug D-penicillamine or a stereoisomer.

N. Nagata, U Hurtenbach, Ernst Gleichmann · The Journal of Immunology · 1986 · 43 citations

Life Sciences, Immunology, Pharmacology +14

Parathyroid Hormone-Related Protein during Pregnancy and the Perinatal Period

Kazuhiko Seki, Seiji Wada, N. Nagata et al. · Gynecologic and Obstetric Investigation · 2010 · 31 citations

Medicine, Endocrinology, Obstetrics +11